Lersivirine

DRUG6 trials

Sponsors

Pfizer

Conditions

HIV-1Healthy Volunteers

Phase 1

Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)

CompletedNCT00925535

PfizerHealthy Volunteers

Start: 2010-05-31End: 2010-08-31Updated: 2010-09-21

The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects

CompletedNCT00936871

PfizerHealthy Volunteers

Start: 2010-01-31End: 2010-03-31Target: 66Updated: 2010-09-06

Bioavailability Of Lersivirine Single 750 Mg Tablet Versus 3 X 250 Mg Tablets

CompletedNCT01050751

PfizerHealthy Volunteers

Start: 2010-02-28End: 2010-03-31Updated: 2010-03-09

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

CompletedNCT01220232

PfizerHealthy Volunteers

Start: 2010-11-30End: 2011-01-31Updated: 2011-02-04

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

CompletedNCT01230385

PfizerHealthy Volunteers

Start: 2010-10-31End: 2011-05-31Updated: 2011-05-17

Phase 2

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

TerminatedNCT01254656

Start: 2011-02-28End: 2013-04-30Updated: 2014-06-09